Skip to main content
. 2024 Apr 24;15:1372692. doi: 10.3389/fimmu.2024.1372692

Table 1.

Clinical features between high and low TLS subtypes in the SARC cohort.

Variables
n(%)
Overall TLS_H TLS_L P
256(100) 128(50) 128(50)
Age (years) 0.001
 ≤50 51 (19.9) 14 (10.9) 37 (28.9)
 51-70 142 (55.5) 75 (58.6) 67 (52.3)
 >70 63 (24.6) 39 (30.5) 24 (18.8)
Gender <0.001
 Male 117 (45.7) 74 (57.8) 43 (33.6)
 Female 139 (54.3) 54 (42.2) 85(66.4)
Race 0.571
 White 224 (87.5) 114 (89.1) 110 (85.9)
 Other 32 (12.5) 14 (10.9) 18 (14.1)
Histological <0.001
 DDL 58 (22.7) 39 (30.5) 19 (14.8)
 LMS 103 (40.2) 40 (31.2) 63 (49.2)
 MFS 25 (9.8) 18 (14.1) 7 (5.5)
 UPS 49 (19.1) 28 (21.9) 21 (16.4)
 Other 21 (8.2) 3 (2.3) 18 (14.1)
Vital status 0.029
 Dead 98 (38.3) 40 (31.2) 58 (45.3)
 Alive 158 (61.7) 88 (68.8) 70 (54.7)
Tumor status 0.172
 Tumor free 125 (48.8) 70 (54.7) 55 (43.0)
 With tumor 122 (47.7) 54 (42.2) 68 (53.1)
 NA 9 (3.5) 4 (3.1) 5 (3.9)
Surgical margin 0.237
 R0 153 (59.8) 79 (61.7) 74 (57.8)
 R1 67 (26.2) 36 (28.1) 31 (24.2)
 R2 9 (3.5) 2 (1.6) 7 (5.5)
 RX 27 (10.5) 11 (8.6) 16 (12.5)

DDL, Dedifferentiated liposarcoma; LMS, leiomyosarcomas; MFS, Myxofibrosarcoma; UPS, undifferentiated pleomorphic sarcoma; NA, not available.The P value in bold indicated that "P<0.05".